Effect of High Cocoa Content Chocolate on Health in Postmenopausal Women.

Sponsor
Fundacion para la Investigacion y Formacion en Ciencias de la Salud (Other)
Overall Status
Completed
CT.gov ID
NCT03492983
Collaborator
Castilla-León Health Service (Other)
140
1
2
15
9.3

Study Details

Study Description

Brief Summary

This is a randomized clinical trial aimed at postmenopausal women aged 50 to 64 years old selected in urban primary care centers of two centers (Spain). Its objective is to evaluate the effects of the additional intake of high cocoa content chocolate on blood pressure, vascular function, body composition, quality of life and cognitive performance.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Intervention group
N/A

Detailed Description

  • Objective: To assess the effect at 6 months of the additional intake of 10 g/day of high cocoa content chocolate for 6 months on blood pressure, vascular function, body composition, quality of life and cognitive performance in postmenopausal women.

  • Design and setting: A randomized clinical trial of two parallel groups. Population: 140 postmenopausal women, 50 to 64 aged will be included, selected by consecutive sampling in two primary care centers.

  • Measurements and intervention: Vascular function (blood pressure, augmentation index and Cardio-Ankle Vascular Index), body composition and health-related quality of life will be evaluated. The intervention group will receive a daily supplement of high cocoa content chocolate for 6 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Investigator)
Primary Purpose:
Other
Official Title:
Effect of High Cocoa Content Chocolate on Vascular Function, Body Composition, Health-related Quality of Life and Cognitive Performance in Postmenopausal Women.
Actual Study Start Date :
Jun 1, 2018
Actual Primary Completion Date :
Aug 31, 2019
Actual Study Completion Date :
Aug 31, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

No intervention

Experimental: Intervention group

Addition of 10 g/day of high cocoa content chocolate to the usual diet for six months

Dietary Supplement: Intervention group
10 g/day of high cocoa content chocolate for six months.

Outcome Measures

Primary Outcome Measures

  1. Blood pressure [6 months]

    Measurement by oscillometric method (mmHg)

Secondary Outcome Measures

  1. Arterial stiffness [6 months]

    Measurement by Brachial-ankle pulse wave velocity (m/s)

  2. Wave reflection [6 months]

    Measurement by central and peripheral augmentation index

  3. Body composition [6 months]

    Measurement by body fat percentage

  4. Quality of life [6 months]

    Measurement by Cervantes Scale (Score between 0 (poor quality) and 155 (high quality)

  5. Cognitive performance [6 months]

    Measurement by executive function

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 64 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women in postmenopausal period defined as 12 consecutive months of amenorrhea.
Exclusion Criteria:
  • Older than 65 years.

  • Cardiovascular disease (acute myocardial infarction, stroke).

  • Arterial hypertension on treatment.

  • Diabetes mellitus.

  • Dyslipidemia (total cholesterol >250 mg/dL or in lipid-lowering therapy).

  • Clinically demonstrable neurological and/or neuropsychological disorders.

  • Hormone replacement therapy.

  • Allergy and/or intolerance to cocoa or any of the components of the supplement.

  • Hypocaloric diet.

  • Any other circumstance that the investigators consider could interfere with the study procedures.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto Biosanitario de Salamanca. Research unit La Alamedilla Salamanca Spain 37003

Sponsors and Collaborators

  • Fundacion para la Investigacion y Formacion en Ciencias de la Salud
  • Castilla-León Health Service

Investigators

  • Principal Investigator: Jose I Recio-Rodriguez, PhD, University of Salamanca

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fundacion para la Investigacion y Formacion en Ciencias de la Salud
ClinicalTrials.gov Identifier:
NCT03492983
Other Study ID Numbers:
  • GRS 1583/B/17
First Posted:
Apr 10, 2018
Last Update Posted:
Feb 21, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fundacion para la Investigacion y Formacion en Ciencias de la Salud

Study Results

No Results Posted as of Feb 21, 2020